In this episode of the “CURE Talks Cancer” podcast we spoke with two experts on the treatment landscape of metastatic urothelial carcinoma and what patients have to look forward to.
The treatment paradigm for metastatic urothelial carcinoma has shifted significantly over the last decade with immunotherapy and precision medicine.
In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Elizabeth Plimack, chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, Temple Health, and Dr. Sumanta (Monty) Pal, from City of Hope Comprehensive Cancer Center, about metastatic urothelial.
The experts discussed the treatment landscape for this disease, how patients can learn more about their options and what they have to look forward to on the horizon.
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
March 4th 2024In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Listen
Pulling Back the Layers of Penile Cancer
September 17th 2020In this episode of the “CURE Talks Cancer” podcast, we spoke with an expert about some of the possible causes of penile cancer, as well as why research in the field is severely lacking and why it’s so important to inform the public about what to look for in terms of signs and symptoms of this disease.
Read More